The findings, which suggest that the approach has the potential to be effective against tumors that have already spread to other parts of the body and against different cancer types,
Effective today, Chris Boshoff, M.D., PhD, will join Pfizer's Executive Leadership Team as Chief Oncology Research and Development Officer and Executive Vice President reporting to